Biomarker for craving and acamprosate treatment response in patients with alcohol use disorder: insights from multi-omics.
Saved in:
| Title: | Biomarker for craving and acamprosate treatment response in patients with alcohol use disorder: insights from multi-omics. |
|---|---|
| Authors: | Ho MF; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. ho.mingfen@mayo.edu.; Department of Molecular Pharmacology and Experimental Therapeutics; Mayo Clinic, Rochester, MN, USA. ho.mingfen@mayo.edu., Zhang C; Department of Molecular Pharmacology and Experimental Therapeutics; Mayo Clinic, Rochester, MN, USA., Coombes BJ; Division of Computational Biology, Quantitative Health Sciences; Mayo Clinic, Rochester, MN, USA., Biernacka JM; Division of Computational Biology, Quantitative Health Sciences; Mayo Clinic, Rochester, MN, USA., Croarkin PE; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA., Oesterle TS; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA., Karpyak VM; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA., Li H; Department of Molecular Pharmacology and Experimental Therapeutics; Mayo Clinic, Rochester, MN, USA., Weinshilboum RM; Department of Molecular Pharmacology and Experimental Therapeutics; Mayo Clinic, Rochester, MN, USA. |
| Source: | Molecular psychiatry [Mol Psychiatry] 2026 Jul; Vol. 31 (7), pp. 3746-3757. Date of Electronic Publication: 2026 Feb 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5578 (Electronic) Linking ISSN: 13594184 NLM ISO Abbreviation: Mol Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
